PSMA-targeted nanoparticles delivering ATR and Src/Bcr-Abl inhibitors to stimulate STING and reprogram senescence-associated secretory phenotype for enhancing immunotherapy in prostate cancer

Bioactive Materials · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles